| Sorafenib in advanced hepatocellular carcinoma JM Llovet, S Ricci, V Mazzaferro, P Hilgard, E Gane, JF Blanc, ... New England journal of medicine 359 (4), 378-390, 2008 | 15650 | 2008 |
| Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis K Burak, P Angulo, TM Pasha, K Egan, J Petz, KD Lindor Official journal of the American College of Gastroenterology| ACG 99 (3 …, 2004 | 647 | 2004 |
| Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C KW Burak, WK Kremers, KP Batts, RH Wiesner, CB Rosen, ... Liver Transplantation 8 (4), 362-369, 2002 | 284 | 2002 |
| Portal hypertensive gastropathy and gastric antral vascular ectasia (GAVE) syndrome KW Burak, SS Lee, PL Beck Gut 49 (6), 866-872, 2001 | 283 | 2001 |
| Is there a role for liver biopsy in primary sclerosing cholangitis? KW Burak, P Angulo, KD Lindor Official journal of the American College of Gastroenterology| ACG 98 (5 …, 2003 | 236 | 2003 |
| Management of chronic hepatitis C: consensus guidelines MD Stephen Shafran, MD Kelly Burak, MD Karen Doucette, ... Can J gastroenterol 21, 25C, 2007 | 222* | 2007 |
| A rapid bedside screen to predict unplanned hospitalization and death in outpatients with cirrhosis: a prospective evaluation of the clinical frailty scale P Tandon, N Tangri, L Thomas, L Zenith, T Shaikh, M Carbonneau, M Ma, ... Official journal of the American College of Gastroenterology| ACG 111 (12 …, 2016 | 218 | 2016 |
| Rituximab for the treatment of patients with autoimmune hepatitis who are refractory or intolerant to standard therapy KW Burak, MG Swain, T Santodomino-Garzon, SS Lee, SJ Urbanski, ... Canadian Journal of Gastroenterology and Hepatology 27 (5), 273-280, 2013 | 204 | 2013 |
| B-cell depletion with rituximab in patients with primary biliary cirrhosis refractory to ursodeoxycholic acid RP Myers, MG Swain, SS Lee, AAM Shaheen, KW Burak Official journal of the American College of Gastroenterology| ACG 108 (6 …, 2013 | 174 | 2013 |
| Prediction of cardiac complications after liver transplantation TR Fouad, WM Abdel-Razek, KW Burak, VG Bain, SS Lee Transplantation 87 (5), 763-770, 2009 | 169 | 2009 |
| Epidemiology and natural history of primary biliary cirrhosis in a Canadian health region: a population‐based study RP Myers, AAM Shaheen, A Fong, KW Burak, A Wan, MG Swain, ... Hepatology 50 (6), 1884-1892, 2009 | 163 | 2009 |
| The management of chronic hepatitis C: 2018 guideline update from the Canadian Association for the Study of the Liver H Shah, M Bilodeau, KW Burak, C Cooper, M Klein, A Ramji, D Smyth, ... Cmaj 190 (22), E677-E687, 2018 | 159 | 2018 |
| Involvement in teaching improves learning in medical students: a randomized cross-over study AD Peets, S Coderre, B Wright, D Jenkins, K Burak, S Leskosky, ... BMC medical education 9, 1-5, 2009 | 151 | 2009 |
| Maintenance therapy with peginterferon alfa-2b does not prevent hepatocellular carcinoma in cirrhotic patients with chronic hepatitis C J Bruix, T Poynard, M Colombo, E Schiff, K Burak, EJL Heathcote, T Berg, ... Gastroenterology 140 (7), 1990-1999, 2011 | 147 | 2011 |
| Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory to standard therapy SM Devlin, MG Swain, SJ Urbanski, KW Burak Canadian Journal of Gastroenterology and Hepatology 18 (5), 321-326, 2004 | 141 | 2004 |
| Gender, renal function, and outcomes on the liver transplant waiting list: assessment of revised MELD including estimated glomerular filtration rate RP Myers, AAM Shaheen, AI Aspinall, RR Quinn, KW Burak Journal of hepatology 54 (3), 462-470, 2011 | 137 | 2011 |
| Management of chronic hepatitis B: consensus guidelines M Sherman, S Shafran, K Burak, K Doucette, W Wong, N Girgrah, ... Canadian Journal of gastroenterology 21 (Suppl C), 5C-24C, 2007 | 136 | 2007 |
| An update on the management of chronic hepatitis C: 2015 Consensus guidelines from the Canadian Association for the Study of the Liver RP Myers, H Shah, KW Burak, C Cooper, JJ Feld Canadian Journal of Gastroenterology and Hepatology 29 (1), 19-34, 2015 | 130 | 2015 |
| Successful treatment of refractory type 1 autoimmune hepatitis with methotrexate KW Burak, SJ Urbanski, MG Swain Journal of hepatology 29 (6), 990-993, 1998 | 130 | 1998 |
| The pathogenesis of hepatitis C virus is influenced by cytomegalovirus RR Razonable, KW Burak, H Van Cruijsen, RA Brown, MR Charlton, ... Clinical infectious diseases 35 (8), 974-981, 2002 | 120 | 2002 |